MP53-01 DOES BASELINE SERUM TESTOSTERONE INFLUENCE ANDROGEN DEPRIVATION THERAPY OUTCOMES FOR ADVANCED PROSTATE CANCER PATIENTS

Anup Patel

doi:10.1016/j.juro.2017.02.1652

MP53-01 DOES BASELINE SERUM TESTOSTERONE INFLUENCE ANDROGEN DEPRIVATION THERAPY OUTCOMES FOR ADVANCED PROSTATE CANCER PATIENTS

The Journal of Urology ◽

10.1016/j.juro.2017.02.1652 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Anup Patel

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Advanced Prostate Cancer ◽

Serum Testosterone ◽

Androgen Deprivation ◽

Therapy Outcomes ◽

Baseline Serum

Download Full-text

Baseline serum testosterone - does it influence androgen deprivation therapy outcomes in hormone naïve advanced prostate cancer patients?

European Urology Supplements ◽

10.1016/s1569-9056(19)31010-3 ◽

2019 ◽

Vol 18 (1) ◽

pp. e1397

Author(s):

A. Patel

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Advanced Prostate Cancer ◽

Serum Testosterone ◽

Androgen Deprivation ◽

Therapy Outcomes ◽

Baseline Serum

Download Full-text

PD25-03 DOES BASELINE SERUM TESTOSTERONE INFLUENCE ANDROGEN DEPRIVATION THERAPY OUTCOMES IN HORMONE NAïVE ADVANCED PROSTATE CANCER PATIENTS?

The Journal of Urology ◽

10.1097/01.ju.0000555904.16943.74 ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

Anup Patel*

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Advanced Prostate Cancer ◽

Serum Testosterone ◽

Androgen Deprivation ◽

Therapy Outcomes ◽

Baseline Serum

Download Full-text

Does Baseline Serum Testosterone Influence Androgen Deprivation Therapy Outcomes in Hormone Naïve Patients with Advanced Prostate Cancer?

The Journal of Urology ◽

10.1097/ju.0000000000001413 ◽

2020 ◽

Author(s):

Anup Patel

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Advanced Prostate Cancer ◽

Serum Testosterone ◽

Androgen Deprivation ◽

Therapy Outcomes ◽

Baseline Serum

Download Full-text

Predictive Clinical Indicators of Biochemical Progression in Advanced Prostate Cancer Patients Receiving Leuplin Depot as Androgen Deprivation Therapy

PLoS ONE ◽

10.1371/journal.pone.0105091 ◽

2014 ◽

Vol 9 (8) ◽

pp. e105091 ◽

Cited By ~ 3

Author(s):

Chien-Hua Chen ◽

Ju-Ton Hsieh ◽

Kuo-How Huang ◽

Yeong-Shiau Pu ◽

Hong-Chiang Chang

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Advanced Prostate Cancer ◽

Androgen Deprivation ◽

Clinical Indicators ◽

Biochemical Progression

Download Full-text

Population-Based Comparison Of The Risks Of Serious Adverse Events From Intermittent Versus Continuous Androgen Deprivation Therapy In Advanced Prostate Cancer Patients

Value in Health ◽

10.1016/j.jval.2016.03.1627 ◽

2016 ◽

Vol 19 (3) ◽

pp. A134

Author(s):

H Tsai ◽

R Pfeiffer ◽

G Philips ◽

A Barac ◽

AZ Fu ◽

...

Keyword(s):

Prostate Cancer ◽

Adverse Events ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Advanced Prostate Cancer ◽

Population Based ◽

Androgen Deprivation ◽

Serious Adverse Events

Download Full-text

The effect of statins on advanced prostate cancer patients with androgen deprivation therapy or abiraterone/enzalutamide: A systematic review and meta‐analysis

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13092 ◽

2020 ◽

Vol 45 (3) ◽

pp. 488-495 ◽

Cited By ~ 2

Author(s):

Hui Yang ◽

Lizhen Pang ◽

Xiaopeng Hu ◽

Wei Wang ◽

Bifang Xu ◽

...

Keyword(s):

Prostate Cancer ◽

Systematic Review ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Advanced Prostate Cancer ◽

Meta Analysis ◽

Androgen Deprivation

Download Full-text

The impact of baseline serum testosterone and duration of first-line androgen deprivation therapy on the efficacy of docetaxel in patients with metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.5043 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 5043-5043

Author(s):

Robert J. van Soest ◽

Mario A. Eisenberger ◽

Florence Mercier ◽

Ian Tannock ◽

Ronald De Wit

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Serum Testosterone ◽

Androgen Deprivation ◽

Castration Resistant Prostate Cancer ◽

First Line ◽

Baseline Serum ◽

Castration Resistant ◽

The Impact

Download Full-text

2061 GENETIC POLYMORPHISM INFLUENCES INDIVIDUAL VARIATIONS IN SERUM TESTOSTERONE LEVELS IN PROSTATE CANCER PATIENTS TREATED WITH ANDROGEN DEPRIVATION THERAPY

The Journal of Urology ◽

10.1016/j.juro.2010.02.2108 ◽

2010 ◽

Vol 183 (4S) ◽

Author(s):

Shintaro Narita ◽

Kazuyuki Numakura ◽

Takashi Obara ◽

Hiroshi Tsuruta ◽

Mitsuru Saito ◽

...

Keyword(s):

Prostate Cancer ◽

Genetic Polymorphism ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Serum Testosterone ◽

Androgen Deprivation ◽

Testosterone Levels ◽

Individual Variations

Download Full-text

939 PROGNOSTIC ROLE OF SERUM TESTOSTERONE LEVELS IN PROSTATE CANCER PATIENTS DURING ANDROGEN-DEPRIVATION THERAPY

The Journal of Urology ◽

10.1016/j.juro.2012.02.1037 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

Francesco Porpiglia ◽

Cristian Fiori ◽

Valentina Bertaglia ◽

Marcello Tucci ◽

Emiliano Aroasio ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Serum Testosterone ◽

Androgen Deprivation ◽

Prognostic Role ◽

Testosterone Levels

Download Full-text

Recovery of serum testosterone following neoadjuvant androgen deprivation therapy in Japanese prostate cancer patients treated with low-dose rate brachytherapy

The Aging Male ◽

10.1080/13685538.2020.1731450 ◽

2020 ◽

pp. 1-7

Author(s):

Yuki Kato ◽

Kazuyoshi Shigehara ◽

Shohei Kawaguchi ◽

Kouji Izumi ◽

Yoshifumi Kadono ◽

...

Keyword(s):

Prostate Cancer ◽

Dose Rate ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Low Dose ◽

Serum Testosterone ◽

Androgen Deprivation ◽

Low Dose Rate ◽

Low Dose Rate Brachytherapy

Download Full-text